The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Purkins, Lynn, Dr
    Consultant born in April 1964
    Individual (4 offsprings)
    Officer
    2011-06-11 ~ dissolved
    OF - Director → CIF 0
    Dr Lynn Purkins
    Born in April 1964
    Individual (4 offsprings)
    Person with significant control
    2017-06-09 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
  • 2
    Sanders, Bruce
    Director born in December 1961
    Individual (1 offspring)
    Officer
    2011-06-10 ~ dissolved
    OF - Director → CIF 0
Ceased 1
  • Purkins, Lynn, Dr
    Consultant born in April 1964
    Individual (4 offsprings)
    Officer
    2011-06-10 ~ 2011-06-11
    OF - Director → CIF 0
parent relation
Company in focus

PURKINS PHARMA CONSULTING LIMITED

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Par Value of Share
Class 1 ordinary share
12020-07-01 ~ 2021-06-30
Property, Plant & Equipment
64 GBP2021-06-30
75 GBP2020-06-30
Cash at bank and in hand
89,910 GBP2021-06-30
101,670 GBP2020-06-30
Creditors
Current
8,274 GBP2021-06-30
14,057 GBP2020-06-30
Net Current Assets/Liabilities
81,636 GBP2021-06-30
87,613 GBP2020-06-30
Total Assets Less Current Liabilities
81,700 GBP2021-06-30
87,688 GBP2020-06-30
Equity
Called up share capital
100 GBP2021-06-30
100 GBP2020-06-30
Retained earnings (accumulated losses)
81,600 GBP2021-06-30
87,588 GBP2020-06-30
Equity
81,700 GBP2021-06-30
87,688 GBP2020-06-30
Average Number of Employees
22020-07-01 ~ 2021-06-30
22019-07-01 ~ 2020-06-30
Property, Plant & Equipment - Gross Cost
Furniture and fittings
296 GBP2020-06-30
Computers
1,165 GBP2020-06-30
Property, Plant & Equipment - Gross Cost
1,461 GBP2020-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
232 GBP2021-06-30
221 GBP2020-06-30
Computers
1,165 GBP2021-06-30
1,165 GBP2020-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,397 GBP2021-06-30
1,386 GBP2020-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
11 GBP2020-07-01 ~ 2021-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
11 GBP2020-07-01 ~ 2021-06-30
Property, Plant & Equipment
Furniture and fittings
64 GBP2021-06-30
75 GBP2020-06-30
Other Creditors
Current
4,000 GBP2020-06-30
Accrued Liabilities
Current
517 GBP2021-06-30
492 GBP2020-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2021-06-30

  • PURKINS PHARMA CONSULTING LIMITED
    Info
    Registered number 07664879
    45 Queen Street, Deal, Kent CT14 6EY
    Private Limited Company incorporated on 2011-06-10 and dissolved on 2023-08-01 (12 years 1 month). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.